2026-07-13
Semaglutide API Catalog Review: COA, HPLC, MS and NMR Points
This article provides a detailed review of Semaglutide API quality documentation focusing on Certificate of Analysis (COA), HPLC, Mass Spectrometry (MS), and Nuclear Magnetic Resonance (NMR) data points essential for supplier evaluation and procurement decisions in pharmaceutical manufacturing.
Source references
- ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Guidance on quality management and documentation requirements for API manufacturing and supplier evaluation
- FDA Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration (FDA)
Standards for analytical method validation including HPLC, MS, and NMR data in pharmaceutical quality control
- European Pharmacopoeia Monograph for Semaglutide
European Directorate for the Quality of Medicines & HealthCare (EDQM)
Official monograph standards for Semaglutide API quality and impurity profiling
